Cargando…

Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling

The acetylcholinesterase inhibitors donepezil and rivastigmine have been used as therapeutic drugs for Alzheimer’s disease (AD), but their effects on LPS- and Aβ-induced neuroinflammatory responses and the underlying molecular pathways have not been studied in detail in vitro and in vivo. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jieun, Lee, Hyun-ju, Park, Seon Kyeong, Park, Jin-Hee, Jeong, Ha-Ram, Lee, Soojung, Lee, Heeyong, Seol, Eunyoung, Hoe, Hyang-Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508964/ https://www.ncbi.nlm.nih.gov/pubmed/34638977 http://dx.doi.org/10.3390/ijms221910637

Ejemplares similares

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
por: Choi, Hee-Jeong, et al.
Publicado: (2022)

Idebenone Regulates Aβ and LPS-Induced Neurogliosis and Cognitive Function Through Inhibition of NLRP3 Inflammasome/IL-1β Axis Activation
por: Lee, Hyun-ju, et al.
Publicado: (2022)

Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
por: Park, Jin-Hee, et al.
Publicado: (2023)

Neuroprotective Effects of Savinin on LPS-Induced Neuroinflammation In Vivo via Regulating MAPK/NF-κB Pathway and NLRP3 Inflammasome Activation
por: Tang, Siqi, et al.
Publicado: (2023)

The Anti-diabetic Drug Gliquidone Modulates Lipopolysaccharide-Mediated Microglial Neuroinflammatory Responses by Inhibiting the NLRP3 Inflammasome
por: Kim, Jieun, et al.
Publicado: (2021)

Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
por: Seo, Hye-Young, et al.
Publicado: (2023)

Sorafenib Modulates the LPS- and Aβ-Induced Neuroinflammatory Response in Cells, Wild-Type Mice, and 5xFAD Mice
por: Kim, Jieun, et al.
Publicado: (2021)

LPS Triggers Acute Neuroinflammation and Parkinsonism Involving NLRP3 Inflammasome Pathway and Mitochondrial CI Dysfunction in the Rat
por: Valenzuela-Arzeta, Irais E., et al.
Publicado: (2023)

NLRP3 Exacerbate NETosis-Associated Neuroinflammation in an LPS-Induced Inflamed Brain
por: Byun, Da Jeong, et al.
Publicado: (2023)

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
por: Lee, Jun Ho, et al.
Publicado: (2021)

NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis
por: Kaushik, Deepak Kumar, et al.
Publicado: (2012)

TARGETING THE NLRP3 INFLAMMASOME IN MECHANISMS OF SLEEP DEPRIVATION-INDUCED NEUROINFLAMMATION
por: Smith, Chad, et al.
Publicado: (2019)

Nilotinib modulates LPS-induced cognitive impairment and neuroinflammatory responses by regulating P38/STAT3 signaling
por: Kim, Jieun, et al.
Publicado: (2022)

Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
por: Yang, Chul-Su, et al.
Publicado: (2015)

Targeting TBK1 Attenuates LPS-Induced NLRP3 Inflammasome Activation by Regulating of mTORC1 Pathways in Trophoblasts
por: Lee, Sohee, et al.
Publicado: (2021)

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
por: Akther, Mahbuba, et al.
Publicado: (2021)

SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts
por: Park, Sumi, et al.
Publicado: (2020)

TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia
por: Zhang, Yahui, et al.
Publicado: (2021)

GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
por: Qin, Zhangjin, et al.
Publicado: (2022)

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
por: Han, Qiu-Qin, et al.
Publicado: (2023)

Effects of α-lipoic acid on LPS-induced neuroinflammation and NLRP3 inflammasome activation through the regulation of BV-2 microglial cells activation
por: Kim, Su Min, et al.
Publicado: (2019)

Nordalbergin Exerts Anti-Neuroinflammatory Effects by Attenuating MAPK Signaling Pathway, NLRP3 Inflammasome Activation and ROS Production in LPS-Stimulated BV2 Microglia
por: Lo, Jung, et al.
Publicado: (2023)

Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
por: Huang, Chi-Han, et al.
Publicado: (2021)

Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
por: Lo, Jung, et al.
Publicado: (2022)

Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
por: Su, Chia-Cheng, et al.
Publicado: (2021)

lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
por: Xue, Zhenyi, et al.
Publicado: (2018)

Gastrodin improves neuroinflammation-induced cognitive dysfunction in rats by regulating NLRP3 inflammasome
por: Zheng, Xue, et al.
Publicado: (2022)

Editorial: The NLRP3 inflammasome-mediated neuroinflammation and its related mitochondrial impairment in neurodegeneration
por: Deng, Chao, et al.
Publicado: (2023)

Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease
por: Kim, En Hyung, et al.
Publicado: (2015)

MARCH5‐dependent NLRP3 ubiquitination is required for mitochondrial NLRP3‐NEK7 complex formation and NLRP3 inflammasome activation
por: Park, Yeon‐Ji, et al.
Publicado: (2023)

Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury
por: Kim, Su-Mi, et al.
Publicado: (2018)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation
por: Lee, Eun Hye, et al.
Publicado: (2021)

Defective mitochondrial fission augments NLRP3 inflammasome activation
por: Park, Sangjun, et al.
Publicado: (2015)

Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
por: Lee, Hye-Mi, et al.
Publicado: (2013)

Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/NLRP3 Inflammasome Pathway
por: Kang, Jian, et al.
Publicado: (2022)

Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
por: Huang, Ming-Yii, et al.
Publicado: (2018)

Corticosterone Inhibits LPS-Induced NLRP3 Inflammasome Priming in Macrophages by Suppressing Xanthine Oxidase
por: Wu, Ling, et al.
Publicado: (2020)

Cystatin C Deficiency Increases LPS-Induced Sepsis and NLRP3 Inflammasome Activation in Mice
por: Biasizzo, Monika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8fttkogm02ke2nd2q0fv5lna36